Sii Investments Inc. WI decreased its position in shares of Novo Nordisk A/S (NYSE:NVO) by 3.5% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 39,631 shares of the company’s stock after selling 1,422 shares during the period. Sii Investments Inc. WI’s holdings in Novo Nordisk A/S were worth $1,358,000 as of its most recent SEC filing.
A number of other large investors have also added to or reduced their stakes in the stock. Two Sigma Investments LP boosted its position in Novo Nordisk A/S by 68.2% in the fourth quarter. Two Sigma Investments LP now owns 701,089 shares of the company’s stock worth $25,141,000 after buying an additional 284,161 shares during the period. SRS Capital Advisors Inc. acquired a new position in shares of Novo Nordisk A/S during the fourth quarter valued at about $125,000. Moloney Securities Asset Management LLC acquired a new position in shares of Novo Nordisk A/S during the fourth quarter valued at about $992,000. Fiera Capital Corp boosted its position in shares of Novo Nordisk A/S by 6.5% in the fourth quarter. Fiera Capital Corp now owns 148,921 shares of the company’s stock valued at $5,340,000 after buying an additional 9,074 shares during the last quarter. Finally, Guardian Capital Advisors LP boosted its position in shares of Novo Nordisk A/S by 6.8% in the fourth quarter. Guardian Capital Advisors LP now owns 68,725 shares of the company’s stock valued at $2,547,000 after buying an additional 4,395 shares during the last quarter. 6.38% of the stock is currently owned by institutional investors.
Shares of Novo Nordisk A/S (NVO) traded up 1.43% during trading on Friday, reaching $43.20. 2,753,595 shares of the company traded hands. The stock’s 50 day moving average is $41.47 and its 200 day moving average is $36.69. Novo Nordisk A/S has a 1-year low of $30.89 and a 1-year high of $57.41. The company has a market capitalization of $107.82 billion, a price-to-earnings ratio of 18.86 and a beta of 0.67.
COPYRIGHT VIOLATION WARNING: This report was reported by WKRB News and is the sole property of of WKRB News. If you are reading this report on another website, it was illegally copied and reposted in violation of US & international trademark and copyright laws. The original version of this report can be accessed at https://www.wkrb13.com/markets/2228764/novo-nordisk-as-nvo-stake-cut-by-sii-investments-inc-wi.html.
Several research analysts have issued reports on NVO shares. Zacks Investment Research cut shares of Novo Nordisk A/S from a “hold” rating to a “sell” rating in a report on Wednesday, April 19th. Barclays PLC assumed coverage on shares of Novo Nordisk A/S in a research report on Tuesday, March 7th. They set an “underweight” rating for the company. TheStreet raised shares of Novo Nordisk A/S from a “c+” rating to a “b-” rating in a research report on Tuesday, May 2nd. HSBC Holdings plc lowered shares of Novo Nordisk A/S from a “hold” rating to a “reduce” rating in a research report on Friday, April 7th. Finally, BidaskClub raised shares of Novo Nordisk A/S from a “hold” rating to a “buy” rating in a research report on Thursday. Four research analysts have rated the stock with a sell rating, seven have given a hold rating and five have assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus target price of $57.00.
About Novo Nordisk A/S
Novo Nordisk A/S is a global healthcare company engaged in diabetes care. The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The Company’s diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs.
Want to see what other hedge funds are holding NVO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Novo Nordisk A/S (NYSE:NVO).
This story was originally published by WKRB News (https://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://www.wkrb13.com/markets/2228764/novo-nordisk-as-nvo-stake-cut-by-sii-investments-inc-wi.html
Receive News & Ratings for Novo Nordisk A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novo Nordisk A/S and related companies with MarketBeat.com's FREE daily email newsletter.